112 related articles for article (PubMed ID: 34597175)
21. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
22. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
[TBL] [Abstract][Full Text] [Related]
23. Split-face study using a 1,927-nm thulium fiber fractional laser to treat photoaging and melasma in Asian skin.
Lee HM; Haw S; Kim JK; Chang SE; Lee MW
Dermatol Surg; 2013 Jun; 39(6):879-88. PubMed ID: 23465065
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
Kauvar AN
Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
[TBL] [Abstract][Full Text] [Related]
25. New Protocol for Long-Term Results With a Multi-Pulse Nd:YAG Laser for Melasma Treatment: A Descriptive Cohort Study.
Ocampo JCV; Ocampo SV; Vélez NC; Braun M
J Drugs Dermatol; 2021 Feb; 20(2):150-154. PubMed ID: 33538564
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.
Kung KY; Shek SY; Yeung CK; Chan HH
Lasers Surg Med; 2019 Jan; 51(1):14-22. PubMed ID: 30357871
[TBL] [Abstract][Full Text] [Related]
28. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
29. The dermoscopic characteristics of melasma in relation to different skin phototypes, distribution patterns and wood lamp findings: a cross-sectional study of 236 melasma lesions.
Bostan E; Cakir A
Arch Dermatol Res; 2023 Sep; 315(7):1927-1938. PubMed ID: 36853510
[TBL] [Abstract][Full Text] [Related]
30. Use of Picosecond Laser for Melasma Treatment: A Narrative Review.
Pimentel B; Palmeiro A; Castro C; Silva L; Catorze MG; João AL
Photobiomodul Photomed Laser Surg; 2023 Dec; 41(12):674-682. PubMed ID: 38085187
[No Abstract] [Full Text] [Related]
31. Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): A study on related factors in the Chinese population.
Wang B; Xie HF; Tan J; Xie HJ; Xu LY; Ding R; Liu FF; Chen X; Jian D; Li J
J Dermatol; 2016 Jun; 43(6):655-61. PubMed ID: 26777390
[TBL] [Abstract][Full Text] [Related]
32. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma.
Tannous ZS; Astner S
J Cosmet Laser Ther; 2005 Mar; 7(1):39-43. PubMed ID: 16020216
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
Mohamed EM; Younes AH; Hussein GM
J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
[TBL] [Abstract][Full Text] [Related]
34. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
Lee DB; Suh HS; Choi YS
J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
[TBL] [Abstract][Full Text] [Related]
36. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
37. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
38. Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
Polder KD; Bruce S
Dermatol Surg; 2012 Feb; 38(2):199-206. PubMed ID: 22093448
[TBL] [Abstract][Full Text] [Related]
39. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
Polnikorn N
J Cosmet Laser Ther; 2010 Jun; 12(3):126-31. PubMed ID: 20482238
[TBL] [Abstract][Full Text] [Related]
40. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women.
Tamega Ade A; Miot LD; Bonfietti C; Gige TC; Marques ME; Miot HA
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):151-6. PubMed ID: 22212073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
